YAP1 Regulation of cardiomyocyte proliferation, function, and regeneration

Information

  • Research Project
  • 9212191
  • ApplicationId
    9212191
  • Core Project Number
    R01HL116461
  • Full Project Number
    5R01HL116461-05
  • Serial Number
    116461
  • FOA Number
    PA-11-260
  • Sub Project Id
  • Project Start Date
    2/1/2013 - 11 years ago
  • Project End Date
    1/31/2018 - 6 years ago
  • Program Officer Name
    SCHRAMM, CHARLENE A.
  • Budget Start Date
    2/1/2017 - 7 years ago
  • Budget End Date
    1/31/2018 - 6 years ago
  • Fiscal Year
    2017
  • Support Year
    05
  • Suffix
  • Award Notice Date
    1/25/2017 - 7 years ago

YAP1 Regulation of cardiomyocyte proliferation, function, and regeneration

DESCRIPTION (provided by applicant): Improved understanding of cardiac growth control mechanisms is needed to better treat heart disease, as abnormal cardiac growth underlies a subset of cardiomyopathies while inadequate postnatal cardiomyocyte proliferation poses a barrier to regenerative heart disease therapy. Emerging data indicate that the transcriptional co-regulator YAP1 is a fundamentally important regulator of cellular proliferation and organ size. Recent studies from our lab and others indicate that YAP1 critically regulates heart growth by promoting cardiomyocyte proliferation, including proliferation of trabecular and neonatal cardiomyocytes that are normally withdrawing from the cell cycle. Additional preliminary data indicate that YAP1 is essential for normal adult heart function. Intriguingly, we have also found that YAP1 binds plakoglobin, a human cardiomyopathy disease gene that forms cell adhesion junctions and that likely has additional activities in the nucleus. In this proposal we will expand on these results to gain insights into YAP1 regulation of cardiac growth, function, and regeneration. In the first aim, we will test the hypothesis that inhibitory Hippo kinase signaling upstream of YAP1 is required to limit excessive trabecular cardiomyocyte proliferation. In the second aim, we test the hypothesis that YAP1 mediates nuclear signaling by plakoglobin-containing cell adhesion junctions to regulate fetal heart growth and adult heart function. In the third aim, we test the hypothesis that YAP1 gain of function augments myocardial regeneration in myocardial injury models. Successful execution of these aims will inform efforts to improve heart function and stimulate myocardial regeneration.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R01
  • Administering IC
    HL
  • Application Type
    5
  • Direct Cost Amount
    301738
  • Indirect Cost Amount
    223286
  • Total Cost
    525024
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:525024\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    CHILDREN'S HOSPITAL CORPORATION
  • Organization Department
  • Organization DUNS
    076593722
  • Organization City
    BOSTON
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    021155724
  • Organization District
    UNITED STATES